Farooqi, A.A. | Qureshi, M.Z. | Khalid, S. | Attar, Rukset | Martinelli, C. | Sabitaliyevich, U.Y. | Xu, B.
Article | 2019 | Cancers11 ( 4 )
There has been a renewed interest in the identification of natural products having premium pharmacological properties and minimum off-target effects. In accordance with this approach, natural product research has experienced an exponential growth in the past two decades and has yielded a stream of preclinical and clinical insights which have deeply improved our knowledge related to the multifaceted nature of cancer and strategies to therapeutically target deregulated signaling pathways in different cancers. In this review, we have set the spotlight on the scientifically proven ability of berberine to effectively target a myriad of d . . .eregulated pathways. © 2019 by the authors. Licensee MDPI, Basel, Switzerland